Employers Applaud Advancement of the CREATES Act and Transparency Measures, View 2020 as a Transformational Year in Drug Pricing

Employers’ Prescription for Affordable Drugs (EmployersRx) applauded Congress for including the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act and portions of the Biologic Patent Transparency Act in an omnibus government funding package announced this week. EmployersRx welcomed this legislation and encouraged lawmakers to continue negotiation on comprehensive, transformative legislation that can lower drug costs.

ERIC Fights Surprise Billing Arbitration Legislation in the Ohio Senate

Today, ERIC advocated against legislation introduced by the Ohio State Senate’s Committee on Insurance and Financial Institutions. ERIC’s testimony focused on S.B. 198, legislation that would end surprise billing in fully-insured plans in the state, using an arbitration mechanism and focused on provider’s billed charges.